Goshua G - Search Results

1

Global Health Resource Utilization and Cost-Effectiveness of Therapeutics and Diagnostics in Immune Thrombotic Thrombocytopenic Purpura (TTP).

Butt A, Allen C, Purcell A, Ito S, Goshua G. Butt A, et al. Among authors: goshua g. J Clin Med. 2023 Jul 25;12(15):4887. doi: 10.3390/jcm12154887. J Clin Med. 2023. PMID: 37568288 Free PMC article. Review.

2

Cost savings to hospital of rituximab use in severe autoimmune acquired thrombotic thrombocytopenic purpura.

Goshua G, Gokhale A, Hendrickson JE, Tormey C, Lee AI. Goshua G, et al. Blood Adv. 2020 Feb 11;4(3):539-545. doi: 10.1182/bloodadvances.2019000827. Blood Adv. 2020. PMID: 32045473 Free PMC article.

3

Cost effectiveness of caplacizumab in acquired thrombotic thrombocytopenic purpura.

Goshua G, Sinha P, Hendrickson JE, Tormey C, Bendapudi PK, Lee AI. Goshua G, et al. Blood. 2021 Feb 18;137(7):969-976. doi: 10.1182/blood.2020006052. Blood. 2021. PMID: 33280030 Free PMC article.

4

Immunothrombosis: a COVID-19 concerto.

Goshua G, Butt A, Lee AI. Goshua G, et al. Br J Haematol. 2021 Aug;194(3):491-493. doi: 10.1111/bjh.17666. Epub 2021 Jul 7. Br J Haematol. 2021. PMID: 34114208 No abstract available.

5

Association of iron infusion reactions with ABO blood type.

Butt A, Muradashvili T, Soliman S, Li F, Burns AJ, Brooks A, Browning S, Bar N, Borgman G, Goshua G, Hwa J, Martin K, Rinder H, Tormey C, Pine AB, Bona RD, Lee AI, Neparidze N. Butt A, et al. Among authors: goshua g. Eur J Haematol. 2022 Nov;109(5):519-525. doi: 10.1111/ejh.13838. Epub 2022 Aug 9. Eur J Haematol. 2022. PMID: 35871468

6

Apixaban at Apex? Aligning Drug Pricing With Value in Cancer-Associated Thrombosis.

Ito S, Goshua G. Ito S, et al. Among authors: goshua g. Ann Intern Med. 2023 Jan;176(1):125-126. doi: 10.7326/M22-3404. Epub 2022 Dec 27. Ann Intern Med. 2023. PMID: 36571840 No abstract available.

7

Distributional Cost-Effectiveness of Equity-Enhancing Gene Therapy in Sickle Cell Disease in the United States.

Goshua G, Calhoun C, Ito S, James LP, Luviano A, Krishnamurti L, Pandya A. Goshua G, et al. Ann Intern Med. 2023 Jun;176(6):779-787. doi: 10.7326/M22-3272. Epub 2023 May 30. Ann Intern Med. 2023. PMID: 37247420 Free PMC article.

8

Cost-effectiveness of prophylactic emicizumab versus prophylactic recombinant factor VIII in patients with moderate or mild hemophilia A without inhibitors in the United States.

Potnis KC, Viswanathan G, Bona RD, Ito S, Kempton CL, Pandya A, Krumholz HM, Goshua G. Potnis KC, et al. Among authors: goshua g. Am J Hematol. 2023 Sep;98(9):E247-E250. doi: 10.1002/ajh.27014. Epub 2023 Jul 4. Am J Hematol. 2023. PMID: 37401660 Free article.

9

Cost-effectiveness of Tocilizumab in Severe Coronavirus Disease 2019: to See or Not to See.

Pischel L, Goshua G. Pischel L, et al. Among authors: goshua g. Clin Infect Dis. 2021 Dec 6;73(11):2119-2120. doi: 10.1093/cid/ciab459. Clin Infect Dis. 2021. PMID: 33999992 Free PMC article. No abstract available.

10

Cost-effectiveness of second-line therapies in adults with chronic immune thrombocytopenia.

Goshua G, Sinha P, Kunst N, Pischel L, Lee AI, Cuker A. Goshua G, et al. Am J Hematol. 2023 Jan;98(1):122-130. doi: 10.1002/ajh.26497. Epub 2022 Feb 24. Am J Hematol. 2023. PMID: 35147241 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

47 results

Search Page

Filters